Discontinued products

GlaxoSmithKline Ireland would like to inform you that Amoxil capsules 250mg and 500mg were discontinued on the Irish Market from 23rd January 2012.

AstraZeneca Pharmaceuticals (Ireland) Ltd wish to inform you that they are planning to withdraw Betaloc 50mg and 100mg tablets from the Irish market.

In October GlaxoSmithKline (Ireland) Ltd communicated that it was planning to discontinue Amoxil 3g sachets (powder for oral suspension) from 31st October.

GlaxoSmithKline would like to inform you that the following products will no longer be available on the Irish market from the 31st October 2011: • Beconase Nasal Spray 50mcg • Flixonase Nasal Spray 50mcg • Amoxil Sachet 3g • Amoxil Syrup 125mg • Amoxil Syrup Forte 250mg.

LEO Pharma wishes to announce that Dovonex Scalp Solution 60ml is being discontinued from July 2011.

Janssen would like to inform you that the supply of Regranex Gel ceased permanently on June 30th 2011 in Europe.

AstraZeneca will cease to market Pulmicort CFC-Free Inhaler 100 and 200mcg/dose in Ireland.

Novartis Ireland Ltd wish to advise you of their decision to discontinue the distribution of Xolair 150mg Powder and Solution for Injection formulation.

Shire Ireland wishes to announce the discontinuation of Equasym IR (methylphenidate hydrochloride immediate release) tablets from the Irish market effective from February 28th 2011.

AstraZeneca Pharmaceuticals (Ireland) Ltd regrets to announce that due to a recent supply issue, supplies of Bricanyl 500μg/ml Solution for Injection or Infusion have become depleted and will remain so for 2-3 months.